Ryusuke Anan
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- Rheumatoid Arthritis Research and Therapies
- IgG4-Related and Inflammatory Diseases
- Systemic Lupus Erythematosus Research
Papers in
-
- Soft tissue tumor case studies 1
- Systemic Lupus Erythematosus Research 1
-
- SARS-CoV-2 detection and testing 1
- SARS-CoV-2 and COVID-19 Research 1
- COVID-19 Clinical Research Studies 1
- Co-authors
- Ryosuke Arai (1 shared paper)Yasushi Nakano (1 shared paper)Hideaki Shimizu (1 shared paper)Yuko Kurihara (1 shared paper)Nobuhiko Okabe (1 shared paper)Yukiko Nakajima (1 shared paper)Yuko Kaneko (3 shared papers)Tsutomu Takeuchi (3 shared papers)
- Journals
- Medicine (1 paper)Annals of the Rheumatic Diseases (1 paper)Journal of Infection and Chemotherapy (1 paper)PubMed (1 paper)
- Partner nations
- Japan
In The Last Decade
Ryusuke Anan
4 papers receiving 89 citations
Peers
Comparison fields: 5 of 31
- Infectious Diseases 55
- Rheumatology 22
- Neurology 14
- Oncology 17
- Immunology 12
Countries citing papers authored by Ryusuke Anan
This map shows the geographic impact of Ryusuke Anan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryusuke Anan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryusuke Anan more than expected).
Fields of papers citing papers by Ryusuke Anan
This network shows the impact of papers produced by Ryusuke Anan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryusuke Anan. The network helps show where Ryusuke Anan may publish in the future.
Co-authors
The 18 scholars most cited alongside Ryusuke Anan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 63 | |
| 2 | A single nucleotide polymorphism of TRAF1 predicts the clinical response to anti-TNF treatment in Japanese patients with rheumatoid arthritis. | 2014 | 13 |
| 3 | 2017 | 11 | |
| 4 | 2018 | 2 |
About Ryusuke Anan
Ryusuke Anan is a scholar working on Rheumatology, Infectious Diseases, Nephrology, Oncology and Epidemiology, having authored 4 papers that have together received 89 indexed citations. Recurring topics across this work include Soft tissue tumor case studies (1 paper), Renal Diseases and Glomerulopathies (1 paper), Systemic Lupus Erythematosus Research (1 paper), NF-κB Signaling Pathways (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), SARS-CoV-2 detection and testing (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (55 citations), Rheumatology (22 citations), Neurology (14 citations), Oncology (17 citations) and Immunology (12 citations). Ryusuke Anan has collaborated with scholars based in Japan. Frequent co-authors include Ryosuke Arai, Yasushi Nakano, Hideaki Shimizu, Yuko Kurihara, Nobuhiko Okabe, Yukiko Nakajima, Yuko Kaneko, Tsutomu Takeuchi, Mitsuhiro Akiyama and Kazuko Suzuki. Their work appears in journals such as Medicine, Annals of the Rheumatic Diseases, Journal of Infection and Chemotherapy and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.